AAAAAA

   
Results: 1-12 |
Results: 12
Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and[F-18]deuteroaltanserin
Authors: Soares, JC van Dyck, CH Tan, PZ Zoghbi, SS Garg, P Soufer, R Baldwin, RM Fujita, M Staley, JK Fu, X Amici, L Seibyl, J
Citation: Jc. Soares et al., Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and[F-18]deuteroaltanserin, PSYCH RES-N, 106(2), 2001, pp. 81-93
Hemi-parkinsonism due to a midbrain arteriovenous malformation: Dopamine transporter imaging
Authors: Goldstein, S Friedman, JH Innis, R Seibyl, J Marek, K
Citation: S. Goldstein et al., Hemi-parkinsonism due to a midbrain arteriovenous malformation: Dopamine transporter imaging, MOVEMENT D, 16(2), 2001, pp. 350-353
[I-123]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression
Authors: Marek, K Innis, R van Dyck, C Fussell, B Early, M Eberly, S Oakes, D Seibyl, J
Citation: K. Marek et al., [I-123]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression, NEUROLOGY, 57(11), 2001, pp. 2089-2094
A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPELT in parkinsonism
Authors: Marek, K Seibyl, J Holloway, R Kieburtz, K Oakes, D Lang, A Yim, J Dey, H Cellar, J Fussell, B Broshjeit, S Early, M Smith, EO Sudarsky, L Johnson, KA Corwin, C Johnson, D Lajoie, S Reich, SG Frost, JJ Goldberg, P Flesher, JE Feigin, A Mazurkiewicz, J Castronuovo, J Joseph, F Cove, G DiRocco, A Olanow, CW Machac, J Cotei, D Webner, P Rudolph, A Day, D Casaceli, C Freimuth, A Orme, C Hodgeman, K Eberly, S Henry, E Morgan, G Westwater, D Haley, JB Henry, E
Citation: K. Marek et al., A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPELT in parkinsonism, NEUROLOGY, 57(10), 2001, pp. S52-S59
A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study
Authors: Holloway, R Shoulson, I Fahn, S Kieburtz, K Lang, A Marek, K McDermott, M Seibyl, J Weiner, W Welsh, M Kamp, C Day, D Pahwa, R Smith, D McGuire, D Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Mistura, K Bloomfield, W Miyasaki, J Duff, J Sime, E Suchowersky, O Argatoff, P Andreas, Y Kurth, M Brewer, M Russell, D Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Beach, J Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajout, A Wilson, W McCullan, L Brown, K Clark, R Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Pfeiffer, R Rast, S Bujak, G Casaceli, C Freimuth, A Hodgeman, K Honsinger, K Watts, A Hall, WJ Leventhal, CM Reich, S Tariot, P Balgoyen, D Corak, D Corrigan, M Driver, M Fraser, TJ Lai, PY Gomez-Mancilla, B Munting, J Peters, G Rowland, C Sullivan, H Trasky, R Wright, G Berber, E Morris, J Mills, D Hallak, L Rines, S
Citation: R. Holloway et al., A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study, CLIN NEUROP, 23(1), 2000, pp. 34-44
Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
Authors: Holloway, R Shoulson, I Kieburtz, K McDermott, M Tariot, P Kamp, C Day, D Shinaman, A Fahn, S Lang, A Marek, K Seibyl, J Weiner, W Welsh, M Pahwa, R Coe, S Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Miyasaki, J Duff, J Sime, E Suchowersky, O Stacy, M Kurth, M Brewer, M Harrigan, M Russell, DS Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Atassi, F Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajput, A Shirley, T Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Schuman, S Pfeiffer, R Rast, S Pfeiffer, B Brocht, A Casaceli, C Daigneault, S Hodgeman, K Honsinger, K O'Connell, C Watts, A
Citation: R. Holloway et al., Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial, J AM MED A, 284(15), 2000, pp. 1931-1938
Imaging - A molecular map for neurodegeneration
Authors: Marek, K Seibyl, J
Citation: K. Marek et J. Seibyl, Imaging - A molecular map for neurodegeneration, SCIENCE, 289(5478), 2000, pp. 409-411
A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism
Authors: Marek, K Seibyl, J Holloway, R Kieburtz, K Oakes, D Lang, A Yim, J Dey, H Cellar, J Fussell, B Broshjeit, S Early, M Smith, EO Sudarsky, L Johnson, KA Corwin, C Johnson, D Lajoie, S Reich, SG Frost, JJ Goldberg, P Flesher, JE Feigin, A Mazurkiewicz, J Castronuovo, J Joseph, F DiRocco, A Olanow, CW Machac, J Cotei, D Webner, P Rudolph, A Day, D Casaceli, C Freimuth, A Orme, C Hodgeman, K Eberly, S Henry, E Morgan, G Haley, JB Henry, E
Citation: K. Marek et al., A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism, NEUROLOGY, 55(10), 2000, pp. 1540-1547
Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [I-123]beta-CIT
Authors: Laruelle, M Abi-Dargham, A van Dyck, C Gil, R D'Souza, DC Krystal, J Seibyl, J Baldwin, R Innis, R
Citation: M. Laruelle et al., Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [I-123]beta-CIT, BIOL PSYCHI, 47(5), 2000, pp. 371-379
The role of quantitative ictal SPECT analysis in the evaluation of nonepileptic seizures
Authors: Spanaki, MV Spencer, SS Corsi, M MacMullan, J Seibyl, J Zubal, IG
Citation: Mv. Spanaki et al., The role of quantitative ictal SPECT analysis in the evaluation of nonepileptic seizures, J NEUROIMAG, 9(4), 1999, pp. 210-216
No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia
Authors: Abi-Dargham, A Laruelle, M Krystal, J D'Souza, C Zoghbi, S Baldwin, RM Seibyl, J Mawlawi, O de Erasquin, G Charney, D Innis, RB
Citation: A. Abi-dargham et al., No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia, NEUROPSYCH, 20(6), 1999, pp. 650-661
Sensitivity and specificity of quantitative difference SPECT analysis in seizure localization
Authors: Spanaki, MV Spencer, SS Corsi, M MacMullan, J Seibyl, J Zubal, IG
Citation: Mv. Spanaki et al., Sensitivity and specificity of quantitative difference SPECT analysis in seizure localization, J NUCL MED, 40(5), 1999, pp. 730-736
Risultati: 1-12 |